Lineage Cell Therapeutics, Inc. (LCTX)
USD 0.5
(0.93%)
USD 0.5
(0.93%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -28.56 Million | 1.05 Million | -23.56 Million | -19.75 Million | -31.94 Million | -30.88 Million |
| Net Income | -21.48 Million | -26.35 Million | -43.27 Million | -20.68 Million | -11.82 Million | -46.78 Million |
| Depreciation & Amortization | 692 Thousand | 727 Thousand | 873 Thousand | 2.03 Million | 3 Million | 3.27 Million |
| Deferred income taxes | -1.8 Million | - | -5.99 Million | -1.23 Million | -7.4 Million | -346 Thousand |
| Stock-based compensation | 4.64 Million | 4.28 Million | 3.51 Million | 2.22 Million | 3.58 Million | 5.4 Million |
| Change in working capital | -10.8 Million | 18.66 Million | 21.11 Million | 1.37 Million | -1.95 Million | 638 Thousand |
| Other non-cash items | 195 Thousand | 3.72 Million | 202 Thousand | -3.46 Million | -17.33 Million | 6.93 Million |
| Investing Cash Flow | 46.44 Million | -46.15 Million | 9.74 Million | 13.03 Million | 16.95 Million | 11.81 Million |
| Investments in PPE | -674 Thousand | -413 Thousand | -354 Thousand | -64 Thousand | -440 Thousand | -3.28 Million |
| Acquisitions | 673.99 Thousand | 45.74 Million | 10.08 Million | 13.06 Million | 17.33 Million | 15.11 Million |
| Investment purchases | -16.4 Million | -53.41 Million | 6.02 Million | 4.56 Million | -14.21 Million | -8000.00 |
| Sales/Maturities of investments | 63.52 Million | 7.66 Million | -6.02 Million | -4.56 Million | 14.21 Million | 24.81 Million |
| Other Investing Activities | -674 Thousand | -45.74 Million | 14 Thousand | 41 Thousand | 65 Thousand | -8000.00 |
| Financing Cash Flow | 6.42 Million | 1.63 Million | 36.93 Million | 29.86 Million | 617 Thousand | 5.77 Million |
| Debt repayment | -54 Thousand | -32 Thousand | -20 Thousand | -26 Thousand | -100 Thousand | -349 Thousand |
| Dividends payments | - | - | - | - | -182 Thousand | -34.4 Million |
| Common Stock Repurchased | -37 Thousand | -17 Thousand | -54 Thousand | -27 Thousand | -110 Thousand | -241 Thousand |
| Common Stock Issuance | 6.51 Million | 1.68 Million | 30.86 Million | 5.12 Million | 63 Thousand | 6 Million |
| Other Financing Activities | -37 Thousand | 1.68 Million | 13.37 Million | 49.93 Million | 827 Thousand | 34.77 Million |
| Accounts receivables | -446 Thousand | 50.31 Million | -857 Thousand | 287 Thousand | 467 Thousand | 46 Thousand |
| Accounts payables | -2.29 Million | -18.7 Million | 21.64 Million | 308 Thousand | -2.88 Million | 1.1 Million |
| Inventory | - | - | -72 Thousand | -308 Thousand | 2.88 Million | 122 Thousand |
| Other working capital | -8.06 Million | -12.94 Million | 394 Thousand | 1.08 Million | -2.42 Million | -630 Thousand |
| Cash at beginning of period | 11.35 Million | 56.27 Million | 33.18 Million | 10.09 Million | 24.39 Million | 37.68 Million |
| Cash at end of period | 35.44 Million | 11.93 Million | 56.27 Million | 33.18 Million | 10.09 Million | 24.39 Million |
| Capital Expenditure | -674 Thousand | -413 Thousand | -354 Thousand | -64 Thousand | -440 Thousand | -3.28 Million |
| Effect of forex changes on cash | -250 Thousand | -873 Thousand | -20 Thousand | -63 Thousand | 70 Thousand | 6000.00 |
| Net cash flow / Change in cash | 24.08 Million | -44.34 Million | 23.09 Million | 23.08 Million | -14.3 Million | -13.28 Million |
| Free Cash Flow | -29.24 Million | 646 Thousand | -23.91 Million | -19.81 Million | -32.38 Million | -34.16 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.76 Million | -6.54 Million | -21.48 Million | -4.77 Million | -7.15 Million | -5.2 Million |
| Depreciation & Amortization | 142 Thousand | 175 Thousand | 692 Thousand | 175 Thousand | 176 Thousand | 170 Thousand |
| Deferred income taxes | - | - | -1.8 Million | -554 Thousand | 941 Thousand | 696 Thousand |
| Stock-based compensation | 1.26 Million | 1.16 Million | 4.64 Million | 1.06 Million | 1.26 Million | 1.28 Million |
| Change in working capital | -1.1 Million | -929 Thousand | -10.8 Million | -1.22 Million | -134 Thousand | -3.02 Million |
| Other non-cash items | 2.66 Million | 1.76 Million | 195 Thousand | -698 Thousand | -131 Thousand | -190 Thousand |
| Investing Cash Flow | -8.79 Million | -38 Thousand | 46.44 Million | 9.74 Million | 2.12 Million | 19.15 Million |
| Investments in PPE | -50 Thousand | -38 Thousand | -674 Thousand | -91 Thousand | -139 Thousand | -256 Thousand |
| Acquisitions | - | - | 673.99 Thousand | 21.48 Million | -2.26 Million | -19.41 Million |
| Investment purchases | -8.76 Million | - | -16.4 Million | - | -3.76 Million | -4.91 Million |
| Sales/Maturities of investments | 18 Thousand | - | 63.52 Million | 9.83 Million | 6.02 Million | 24.33 Million |
| Other Investing Activities | -8.74 Million | -38 Thousand | -674 Thousand | 9.83 Million | 2.26 Million | 19.41 Million |
| Financing Cash Flow | 105 Thousand | 14.02 Million | 6.42 Million | -13 Thousand | 807 Thousand | 5.62 Million |
| Debt repayment | -14 Thousand | -13 Thousand | -54 Thousand | -13 Thousand | -12 Thousand | -16 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -23 Thousand | -37 Thousand | 37 Thousand | - | - |
| Common Stock Issuance | 119 Thousand | 14.05 Million | 6.51 Million | -6.67 Million | 819 Thousand | 5.64 Million |
| Other Financing Activities | -1000.00 | -23 Thousand | -37 Thousand | -13 Thousand | -25 Thousand | 5.62 Million |
| Accounts receivables | -160 Thousand | 668 Thousand | -446 Thousand | -305 Thousand | 6000.00 | -242 Thousand |
| Accounts payables | -671 Thousand | -574 Thousand | -2.29 Million | 1.16 Million | 485 Thousand | -478 Thousand |
| Inventory | - | - | - | 7000.00 | -485 Thousand | 478 Thousand |
| Other working capital | -277 Thousand | -1.02 Million | -8.06 Million | -2.08 Million | -140 Thousand | -2.77 Million |
| Cash at beginning of period | 43.57 Million | 35.44 Million | 11.35 Million | 31.47 Million | 34.44 Million | 16.02 Million |
| Cash at end of period | 29.62 Million | 43.57 Million | 35.44 Million | 35.44 Million | 32 Million | 34.44 Million |
| Capital Expenditure | -50 Thousand | -38 Thousand | -674 Thousand | -91 Thousand | -139 Thousand | -256 Thousand |
| Effect of forex changes on cash | -88 Thousand | -70 Thousand | -250 Thousand | 282 Thousand | -340 Thousand | -92 Thousand |
| Net cash flow / Change in cash | -13.95 Million | 8.13 Million | 24.08 Million | 3.96 Million | -2.44 Million | 18.42 Million |
| Free Cash Flow | -5.22 Million | -5.82 Million | -29.24 Million | -6.11 Million | -5.17 Million | -6.52 Million |
CTYP
VMSSF
BITF
6829
3482
PSEC